Loading...
Vitura Health Limited
VIT.AX•ASX
HealthcareDrug Manufacturers - Specialty & Generic
$0.07
$0.002(2.86%)
Vitura Health Limited (VIT.AX) Stock Overview
Explore Vitura Health Limited’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
5.56%
↑ 5.56%
Profit Growth
$0.003
↓ 74.57%
EPS Growth
$0.003
↓ 75.10%
Operating Margin
2.41%
↓ 75.50%
ROE
4.88%
↓ 74.57%
Dividend Yield
0.00%
↓ 3.02%
Analyst Recommendations data is not available for VIT.AXAnalyst Recommendations details for VIT.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. Its brands include CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. The company was incorporated in 2018 and is based in South Yarra, Australia.
CEO
Mr. Geoff Cockerill
Headquarters
PO Box 6168, South Yarra, VIC
Founded
2019